Editorial Perspectives On Patient Recruitment

51. Tread Carefully Into Virtual Clinical Trials 12/21/2020

    With the COVID-19 pandemic’s impact on clinical trials in the U.S. and around the world, everyone is suddenly focused on virtual (decentralized) clinical trials. But if you plan to move your trials to a virtual model, at least one industry executive is recommending that you use caution when doing so. 

52. An ALS Trial Changes The Patient Recruitment Paradigm 10/22/2020

    Kent Leslie, CSO for Amylyx, refers to patient recruitment as the bane of most clinical studies. As is the case in most trials, recruitment for the CENTAUR trial was slow. Although multiple companies competing for the same patients was a likely factor, Leslie also felt a change was needed in the recruitment paradigm.

53. A New Patient-Centric Virtual Trial Targets Rare Cancers 10/20/2020

    The TargetCancer Foundation, with support from Bayer, has launched a study to research genomic testing in people with rare cancers. The study, called TRACK (Target Rare Cancer Knowledge), has already enrolled the first patients in the U.S. Those patients have been diagnosed with rare cancers, including those with cancers of unknown primary (CUP). 

54. How COVID-19 Will Change Clinical Trials And End The Patient Recruitment Challenge 9/17/2020

    Clinical technologies are evolving and promise to change how studies are conducted. Still, change takes time. Most companies do not rush out to embrace every new technology that comes along. The COVID-19 pandemic may be changing that.

55. Online Recruitment & A Virtual Study Net 4,000 Participants For MAGENTA Trial 8/27/2020

    Stand Up To Cancer (SU2C) has been around for more than 10 years. The organization was founded to promote collaborative and innovative cancer research by bringing together the best and brightest minds in the industry. It's recent MAGENTA study recruited nearly 4,000 patients by using online tools and a virtual approach.

56. BMS Uses Virtual Technology To Empower Patient Communities 7/28/2020

    Patient centricity continues to play a pivotal role in how healthcare companies design and build clinical trials. The drive to get the patient voice involved in trial design has resulted in more companies interacting with patients and patient advocacy groups.

57. ADAPTABLE Study Shows The Potential Of Virtual Trials 7/21/2020

    DCRI and PCORI started the ADAPTABLE clinical trial to the effect of different aspirin doses on patients with heart disease. Now that the trial is winding down, it's success has also shown sponsor companies how to successfully navigate a large, virtual clinical trial.

58. Janssen Study Shows How To Create Patient Diversity In Trials 5/21/2020

    Patient diversity is a problem that exists in clinical trials. Participants across all therapeutic areas have tended to be Caucasian and male. With the FDA now pressuring pharma companies to run trials with patients who better resemble the overall population, a scramble is on to make trials more diverse. 

59. Regeneron's COVID-19 Trial Reaches Patients In 5 Days 5/12/2020

    AdventHealth’s most serious COVID-19 patients were in the ICU and needed immediate help. When it learned about a clinical trial being conducted by Regeneron Pharmaceuticals, it acted quickly. “We were able to get this trial up and running in a record period of time,” states Dr. Steven Smith. “We signed the documents with Regeneron and were administering the drug to our patients in less than five days.” 

60. The (Almost) Insurmountable Recruitment Challenges Of Antibiotic Clinical Trials 5/7/2020

    Clinical trials are difficult. Every clinical executive I interview can rattle off a list of challenges they face and how they are attempting to overcome them. Still, anyone who thinks they have it tough conducting trials should pause and have a moment of reflection for those companies fighting to stay afloat in the challenging area of antibiotics.